A synthetic peptide for use as a blocking control in assays to test for specificity of NKX6-3 antibody, Alternative Names: NKX6-3 control peptide, NKX6-3 antibody Blocking Peptide, Anti-NKX6-3 Blocking Peptide, NK6 homeobox 3 Blocking Peptide, FLJ25169 Blocking Peptide, NKX6.3 Blocking Peptide, NKX6-3, NKX-6-3, NKX 6-3, NKX-6-3 Blocking Peptide, NKX 6-3 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
NK6 Homeobox 3 (NKX6-3)
Hintergrund
Nkx6.3 is a new member of the Nkx6 subfamily of homeodomain proteins. Members of the Nkx family of homeodomain proteins are involved in a variety of developmental processes such as cell fate determination in the CNS and in the pancreas. Nkx6.3 is expressed in the developing CNS and gastro-intestinal tract. Nkx6.3 shows a remarkably selective expression in a subpopulation of differentiating V2 neurons at caudal hindbrain levels. In the gut, Nkx6.3 is expressed in duodenal and glandular stomach endoderm and at the end of gestation Nkx6.3 became restricted to the base of the gastric units in the glandular stomach.